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networks by regulating the expression of 
target genes after transcription.[1–4] Gene 
therapy provides an ideal potential tool 
for many diseases by delivering synthetic 
miRNAs to regulate gene expression.[5–7] 
Several vectors have been developed to 
deliver miRNAs to increase gene transfec-
tion, such as viral vectors, liposomes, and 
other vector systems. However, the biolog-
ical toxicity, cellular immunoreactivity, and 
tumorigenicity of viral vectors limit their 
application in vivo.[8,9] Nonviral vectors 
have attracted more attention due to their 
easy synthesis, low immune response, 
high biocompatibility, and improved safety. 
Agomir is a cholesterol-, methylation-, 
and phosphorothioate-modified miRNA 
fragment, which can mimic the function 
of miRNAs to regulate the expression of 
target genes.[10] After cholesterol modifica-
tion, the tail of miRNAs can form micelles 
to promote cellular uptake. Agomir has 
good stability and enhanced transfection 
efficiency in animals, and can penetrate 
the barriers of cell membrane and tissue 
in vivo to enrich target cells.[11] Different Agomir structures 
based on different miRNA structures can effectively regulate the 
expression of target genes, thereby playing a role in the treat-
ment of different diseases.
Gene therapy provides an ideal potential treatment for intervertebral disk 
degeneration by delivering synthetic microRNAs (miRNAs) to regulate the gene 
expression levels. However, it is very challenging to deliver miRNAs directly, 
which leads to inactivation, low transfection efficiency, and short half-life. Here, 
Agomir is loaded in hydrogel to construct a gene-hydrogel microenvironment 
for regulating the synthesis/catabolism balance of the tissue extracellular matrix 
(ECM) to treat degenerative diseases. Agomir is a cholesterol-, methylation-, and 
phosphorothioate-modified miRNA, which can mimic the function of miRNA to 
regulate the expression of the target gene. Agomir874 that mimics miRNA874 
is synthesized to down regulate the expression of matrix metalloproteinases 
(MMPs) in nucleus pulposus (NP). At the same time, a polyethylene glycol 
(PEG) hydrogel is synthesized through Ag-S coordination of 4-arm PEG-SH and 
silver ion solution, which has injectable, self-healing, antimicrobial, degradable, 
and superabsorbent properties and matches perfectly with the mechanism of 
intervertebral disk. By delivering Agomir-loaded PEG-hydrogel to a degenerative 
intervertebral disk, a gene-hydrogel microenvironment is constructed in situ, 
which reduces the expression of MMPs, regulates the synthesis/catabolism 
balance of ECM in the NP of the intervertebral disk, and improves the tissue 
microenvironment regeneration.
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Weinheim. This is an open access article under the terms of the  Creative 
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1. Introduction
In the past decade, it has been increasingly recognized that 
microRNAs (miRNAs) are an important part of gene regulatory 
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Intervertebral disk degeneration (IVDD) is a cascade reac-
tion caused by the change of the nucleus pulposus (NP) 
microenvironment and imbalance of synthesis/catabolism 
of extracellular matrix (ECM).[12,13] The expression of matrix 
 metalloproteinases (MMPs) increases during the process of 
disk  degeneration, which facilitates the catabolism of ECM 
and leads to IVDD.[14,15] In the process of IVDD, abnormal 
expression of different miRNAs is often detected.[16] MiRNAs 
can regulate the expression of MMPs in NP, which may con-
tribute to the development of IVDD.[17] While, few studies 
have been done on treating IVDD with miRNAs and Agomir 
has never been used. Herein, we are trying to find an miRNA 
to regulate MMPs gene expressions, and then synthesize 
the Agomir based on the miRNA structure to achieve a per-
sistent and effective reduction of MMPs activity and ECM 
degradation.
Because of the avascular structure of intervertebral disk,[18] 
systemic administration of miRNA is not effective for IVDD. 
Alternatively, intervertebral injection may better maintain 
the miRNA at the site of action, to achieve a better effect of 
slowing or inhibiting the progress of IVDD. However, the 
intervertebral disk connects two adjacent vertebral bodies and 
is surrounded by ligaments and muscles, which makes the 
intervertebral disk an important load-bearing structure of ver-
tebrates subjecting to forces in different directions at any time. 
The liquid therapeutics is easy to leak out of the intervertebral 
space from the pinhole, which reduces the curative effect of 
drugs and causes leakage-related complications.[19,20] There-
fore, biomaterials are used to deliver and maintain drugs for 
local treatment of intervertebral. Currently, there are mainly 
two types of biomaterials for intervertebral disk repair: bioma-
terials with high mechanical strength and biomaterials with 
certain elasticity and softness. The former ones include plastic 
and metal materials, which are mostly used in the surgical 
treatment of IVDD.[21,22] However, those materials have too 
high mechanical strength that may induce cartilage endplate 
damage and secondary degeneration to adjacent intervertebral 
disk segments. The latter ones include hydrogels and other 
materials, which are not compressive and have poor storage 
and dissipation properties.[23,24] Under pressure, they have 
the tendency to break into small fragments and damage the 
intervertebral disk, and have the risk of inducing the fibrilla-
tion of the intervertebral disk.[25,26] Therefore, a novel inject-
able hydrogel is  necessary to be developed for delivering 
Agomir into the intervertebral space to slow or inhibit the pro-
gress of IVDD.
In this work, a multifunctional polyethylene glycol (PEG)-
hydrogel is synthesized by cross-linking 4-arm SH-PEG with 
Ag+ via Ag–S coordination to have injectable and self-healing 
properties.[27,28] The PEG-hydrogel has favorable Agomir 
loading capacity and can be injected into intervertebral space 
by minimal invasive method. Moreover, the hydrogel can self-
heal to construct gene-hydrogel microenvironment in situ after 
injection, which is supposed to make the hydrogel resistant 
to leakage and broken. And the mechanical strength of the 
PEG-hydrogel is adjustable to match the condition of interver-
tebral disk. By delivering an Agomir, synthesized by special 
chemical modification based on the structure of miRNA 
whose expression is reduced in IVDD, the gene-hydrogel 
microenvironment is constructed in situ by intervertebral 
space injection of Agomir loaded in PEG-hydrogel. And the 
radiology and  histology images harvested from animals are 
used to assess the effect of the gene-hydrogel microenviron-
ment (Scheme 1).
2. Results and Discussion
MiRNA is an important component of the gene regulatory net-
work, which can regulate the expression of target gene after 
transcription and participate in the occurrence of many dis-
eases. Transmitting synthetic miRNAs to regulate the gene 
expression provides an ideal potential therapy for many dis-
eases. However, in consideration of the transfection efficiency 
and cytotoxicity, there are limitations in the use of existing car-
riers. Agomir is an ideal miRNA agonist for direct chemical 
modification of miRNAs.[29] Cholesterol modification makes it 
more affine to cells, methylation and thio-modification provide 
a longer half-life and less inactivation. Local injection of Agomir 
into living tissues and targeted gene therapy of target cells can 
achieve excellent transfection efficiency and lasting action cycle. 
However, there are risks of leakage and easy diffusion in some 
deep tissues, which decreases the effectiveness of the targeted 
therapy. Therefore, an injectable vector is needed to provide a 
good environment for RNA therapy. Injectable biomaterials are 
temperature- and pH-sensitive. However, these materials have 
a physical or chemical change process on the material itself, 
some of which are even irreversible.
In this study, we used a Ag+ and 4-arm SH-PEG to form a 
Ag–SH coordination bond. After mixing the two solutions, 
they quickly gelled to form a translucent, water-rich jelly-like 
hydrogel with a soft and sticky texture (Figure 1a). This Ag–SH 
coordination bond does not require any catalyst and can react 
spontaneously, which makes the hydrogel self-healing.[30,31] 
When the whole hydrogel is cut into half, it can gradually 
merge into a whole hydrogel (Figure 1b) in 10 min. At the 
same time, because the Ag–SH coordination will break under 
the action of larger shear force, PEG-Ag hydrogel can smoothly 
pass through a 1 mL syringe (Figure 1c) to complete the injec-
tion of deep tissue. Rheological analysis of hydrogels revealed 
that the storage modulus G′ of PEG-Ag hydrogel under a static 
condition was about 600 Pa, and the loss modulus G″ was about 
400 Pa. When the hydrogel was applied with a large shear 
force, the storage modulus and loss modulus decreased to 0 Pa 
(Figure 1d). At the same time, the composite viscosity of the 
hydrogel was about 550 Pa s when no force was applied, indi-
cating that the state of the hydrogel was still in a solid state at 
this time. When a larger shear force was applied, the composite 
viscosity decreased to 0 Pa s, indicating that the hydrogel is in 
a fluid state at this time. Once the force is removed, the com-
posite viscosity of the hydrogel rose again to about 600 Pa s, 
indicating that the hydrogel becomes solid again at this time 
(Figure 1e). The PEG-Ag hydrogel is gelled by spontaneous 
formation of coordination bond between Ag–SH. Under the 
action of shear force, the bond will break reversibly, resulting 
in the transformation of the hydrogel into a fluid state, which 
makes the hydrogel injectable. At the same time, the hydrogel 
can spontaneously coordinate to form Ag–SH bond again after 
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injection, and thus, the hydrogel can self-heal in situ and pro-
vide a good environment for genes and drugs.
Hydrogels loaded with water-soluble drugs need to have a 
strong hygroscopic property, which can absorb a large amount 
of water and load drugs at the same time. The PEG-Ag 
hydrogel has a porous and multi-void structure, as shown in 
the scanning electron microscopy (SEM) images (Figure 1f). 
Each void communicates with each other. The structure 
provides the hydrogel a good hygroscopic property. After 
incubation in phosphate-buffered saline (PBS), the swelling 
mass of the hydrogel can reach more than 3000% and keeps 
its water content up to a week. After Agomir874 was added, 
the microstructure of the hydrogel remains unchanged and 
present a loose multi-void structure (Figure 1g) with an 
improved hygroscopic property (Figure 1h). The structure of 
PEG-Ag hydrogel makes it biodegradable. In PBS aqueous 
solution, PEG-Ag can maintain a certain quality in 4 days, 
while the degradation rate of PEG-Ag hydrogel accelerates 
Adv. Sci. 2019, 1902099
Scheme 1. Gene-hydrogel microenvironment for regeneration of IVDD. a) The construction of gene-hydrogel microenvironment. b) The Agomir@PEG 
was injected into the intervertebral space to construct the gene-hydrogel microenvironment. c–e) The multi-functions provided by the gene-hydrogel 
microenvironment, matching the regeneration of IVDD.
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from the fourth day, and only 20% of the mass remains unde-
graded after 8 days (Figure 1i). This degradation rate can pro-
vide a stable microenvironment for Agomir in vivo within 
the first few days, and when Agomir plays a regulatory role, 
it degrades, reduces its influence on the ECM synthesis, and 
promotes the tissue regeneration.
The process of injecting drug is a minimally invasive oper-
ation, however there still exists a certain risk of infection. 
Therefore, special attention should be paid to aseptic tech-
niques.[32] Fortunately, PEG-Ag hydrogels are rich in Ag ions, 
which can destroy sulfur-containing proteins in the bacteria’s 
cell membranes and kill them.[33,34] The sensitivity of Staphy-
lococcus aureus ATCC25923 to Agomir874-loaded PEG hydro-
gels and PEG-hydrogels was determined by a method similar 
to Kirby–Bauer disk diffusion test. The antimicrobial activity 
(Figure 2a) of PEG-hydrogels with or without Agomir874 was 
Adv. Sci. 2019, 1902099
Figure 1. Properties of the PEG-Ag hydrogels. a) The mixture of PEG-thiol and AgNO3 solution. b) The process of self-healing. c) Photograph of 
the injectable hydrogel. d) Strain sweep measurements of the storage moduli (G’ denotes the elastic modulus and G” denotes the loss modulus). 
e) Measure of viscosity parameters in relation to time in seconds. The strain shearing rate alternated between 0.05% strain for 100 s and 500% strain 
for 50 s. f,g) Magnified SEM results (Agomir874 was marked by red circle). h) Swelling percentage. i) Degradation percentage.
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observed, and the addition of Agomir 874 did not affect the 
antimicrobial activity of PEG-hydrogels (Figure 2b).
The biocompatibility is the primary prerequisite for the 
application of biomaterials.[35] Primary NP cells (NPCs) were 
extracted from coccygeal intervertebral disk of rats (Figure S1, 
Supporting Information). Living/dead cell staining showed 
that PEG-Ag hydrogel had little toxicity to human fibroblasts 
(Figure 2c), and the cell activity was close to 100% in 1, 3, and 
5 days, with no statistically significant differences (Figure 2d). 
At the same time, the exudate of 1, 2, 4 days hydrogel was 
used to carry out Cell Counting Kit-8 test on rat NPCs and 
mouse osteoblast precursor 3T3 cells. It was found that the 
exudates of different days had no obvious biological toxicity 
to rat NPCs and mouse osteoblast precursors (Figure S2, Sup-
porting Information). This suggests that the hydrogel can be 
well compatible in different species and tissues without cyto-
toxicity and can be widely used in various tissue regeneration 
processes.
The key pathological mechanism of degenerative diseases 
in human body is that the balance of synthesis/catabolism of 
the ECM is broken. Oversynthesis or degradation of different 
ECM leads to abnormal proliferation or damage of various 
tissues, which results in various diseases.[36] Overexpression 
of MMPs during degeneration leads to excessive degrada-
tion of the ECM of NP, especially type II collagen, resulting 
in disk degeneration, such as loss of water, loss of interverte-
bral space height, and rupture of the NP. Differential expres-
sion of miRNAs in degenerative NP tissues was investigated 
by the data in National Center for Biotechnology Informa-
tion Gene Expression Omnibus database (GSE116726).[37] 
Of 2570 miRNAs detected, miRNA874 was under expressed 
in the degenerative NP tissues compared with the controls 
(Figure 3a). Activating the expression of miRNA874 in NPCs 
by treating with Agomir874 can down-regulate the expres-
sion of MMPs and increase the expression of ECM compo-
nents, especially type II collagen (Figure 3b). Therefore, in 
the early stage of IVDD, Agomir874 based on the structure of 
miRNA874 is able to achieve a  persistent and effective reduc-
tion of MMPs activity and ECM degradation (Figure 3c). Under 
the action of Agomir874, the expression of MMPs in NPCs was 
down-regulated in varying degrees (Figure 3d–g), especially 
in MMP-2 and MMP-13 (Figure 3f,g). MMP-2 is a gelatinase-
like MMP. Its main function is to degrade denatured collagen 
and gelatin. MMP-13 is an interstitial collagenase, which can 
degrade many types of collagen and most proteoglycan mole-
cules. Agomir874 can negatively regulate the expression of 
MMPs, thereby reducing the degradation of ECM synthesized 
by NPCs and increasing the content of ECM (Figure 3h–j), 
especially the content of type II collagen (Figure 3i). Agomir874 
can reverse the imbalance of synthesis/decomposition by 
Adv. Sci. 2019, 1902099
Figure 2. Biological study of hydrogels in vitro. a,b) Antibacterial sensitivity with agar diffusion test. c,d) Live/dead staining of human fibroblasts 
co-cultured with PEG-Ag hydrogel.
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regulating the balance of synthesis/decomposition of the ECM 
of NP and inhibit the degeneration of intervertebral disk. At the 
same time, the in vitro evaluation of NPCs treated by PEG-Ag 
hydrogel-loaded Agomir874 was similar to that by Agomir874 
alone (Figure 3).
Intervertebral disks can provide buffering force and flex-
ibility to spine movement.[38] Therefore, biomaterials injected 
into intervertebral disk should be in good harmony with 
mechanical properties of intervertebral disk, as well as pro-
viding buffering force and flexibility to spine movement. The 
results of single-segment intervertebral biomechanical studies 
(Figure 4a) demonstrate that compared with the Agomir874 
and acupuncture groups, the control and injected groups with 
hydrogel showed improved mechanical properties (Figure 4b). 
According to the range of normal physiological activities, we 
take the first 30% of the deformity rate and calculate the cor-
responding elastic modulus. The results show that there were 
no statistically significant differences between the groups 
injected with hydrogel and the control group. Moreover, there 
was a statistically significant increase of the elastic modulus 
in the acupuncture and the Agomir874 groups. This suggests 
that the mechanical properties of PEG-hydrogel are similar 
to intervertebral disk. Single Agomir874, which exists in the 
form of liquid, tends to leak through the pinhole. This explains 
why the elastic modulus of the Agomir874 group is similar 
to the acupuncture group (Figure 4c). Also, the addition of 
PEG-hydrogel provides extra buffer to adjacent segments 
and protects adjacent intervertebral disks from degeneration 
(Figure 4d).
To further illustrate the in vivo effect of Agomir874-loaded 
PEG-Ag hydrogel, a rat model of IVDD was established as 
described elsewhere[39,40] (Figure 5a). Histologic sections and 
radiology evaluation were recorded at different time points. 
Disk heights can reflect the changes of ECM[41] (Figure 5b). 
In the Agomir874@PEG group, rat IVDD gradually restores 
to normal height, which was similar to the control group. 
In the acupuncture group, rat IVDD gradually collapses. 
The results of the PEG-Ag hydrogel and Agomir874 groups 
Adv. Sci. 2019, 1902099
Figure 3. The effects of Agomir874@PEG on regulating the synthesis/catabolism balance of NPCs in vitro. a) The volcano plot of differential expres-
sion of miRNAs in IVDD. Red circles denote miRNA874 under-expressed in degenerative intervertebral disc. b) Polymerase chain reaction data of gene 
expression in NPCs treated with Agomir874 or Agomir874 NC. c) The diagram of the effects of gene-hydrogel microenvironment on regulating the 
synthesis/catabolism balance. d) Western blotting data showing the levels of down-regulating the expression of MMPs. Western blotting data of the 
levels of e) MMP-1 and f) MMP-2 and g) MMP-13. h) Western blotting data showing the levels of up-regulation of the expression of Col II and Sox-9. 
Western blotting data of the levels of i) Col II and (j) Sox-9.
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were similar to the acupuncture group, indicating that single 
PEG-Ag hydrogel or Agomir874 solution had little therapeutic 
effects (Figure 5c). The results of different time points 
showed that the Agomir874@PEG group had no statistically 
significant difference compared with the control group, while 
the other group showed statistically significant lower disk 
heights (Figure 5d–f). Magnetic resonance imaging (MRI) can 
reflect the water content of IVDD,[42,43] and the higher gray 
scale indicates lower water content (Figure 5g). MRI scan per-
formed 8 weeks after operation showed lower water content 
in the Agomir874@PEG group compared with the control 
group, however there were no statistically significant dif-
ferences. The PEG-Ag hydrogel and Agomir874 groups had 
significantly lower water content, similar to the acupuncture 
group.
Histological sections were obtained 4 and 8 weeks after 
operation. Hematoxylin and eosin (H&E) staining was used 
to observe the NP, annulus fibrosus, and their margin. 
8 weeks after operation, the Agomir874@PEG group showed 
clear border between the NP and annulus fibrosus, as well as 
significant improvement in the NP compared with 4 weeks. 
Furthermore, in the PEG-Ag hydrogel, Agomir874, and acu-
puncture groups, a very vaguely defined border between 
the NP and annulus fibrosus was noted, along with wors-
ened NP status (Figure 6a). Safranin O staining was used 
to observe collagen level in the NP. Compared with the 
control group, collagen level was significantly higher in the 
Agomir874@PEG group and lower in the PEG-Ag hydrogel, 
Agomir874, and acupuncture groups (Figure 6b). The results 
of type II collagen immunohistochemistry demonstrated a 
normal expression of type II collagen and the intact NP in 
the Agomir874@PEG group. In the PEG-Ag hydrogel and 
Agomir874 groups, however, the expression of type II col-
lagen was nearly absent (Figure S3, Supporting Informa-
tion). Histological score was calculated according to previous 
reports.[44,45] In the Agomir874@PEG group, the histological 
score was significantly lower 8 weeks after operation, indi-
cating an inhibition of disk degeneration along with a pro-
cess of regeneration. In the PEG-Ag hydrogel and Agomir874 
groups, the histological score increased over time. Also, at 
4 weeks after operation, both the Agomir874@PEG, PEG-Ag 
hydrogel and Agomir874, groups had higher histological 
score than the control group (Figure 6c). However, at 8 weeks 
post-operation, there were no statistically significant differ-
ences between the Agomir874@PEG and control groups, 
indicating that this healing process occurs after disk degen-
eration and has reversal effect.
Although the PEG-Ag hydrogel can provide structural sup-
port for intervertebral space at early stages, its excellent bio-
degradability leads to decomposition within the first week after 
implantation, and thus, cannot provide long-term support. 
Single Agomir874 can inhibit the MMPs secretion in NPCs and 
regulate the metabolic balance, but abundant RNase existing 
in the intervertebral disk can be destructive to the Agomir874 
solution. Also, liquid form Agomir874 tends to leak through 
the pinhole due to high pressure inside the intervertebral 
disk, leading to decreased amount of effective Agomir874. By 
loading Agomir874 into the PEG-Ag hydrogel, we created a 
Adv. Sci. 2019, 1902099
Figure 4. Single-segment intervertebral biomechanical studies. a) The diagram of single-segment intervertebral biomechanical studies. b) Compres-
sion curve of different treatment at single-segment of intervertebral disk. c) The elastic modulus of the first 30% of the deformity rate. d) The schematic 
diagram of stress dispersion of gene-hydrogel microenvironment.
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gene-hydrogel microenvironment inside the intervertebral disk, 
which can effectively  regulate the anabolism balance during 
IVDD and promote disk regeneration.
3. Conclusion
In conclusion, we demonstrated that Agomir874 based on the 
structure of miRNA874 can down-regulate the expression of 
MMPs, thereby regulating the metabolism balance of ECM in NP 
and slowing the process of IVDD for the first time. At the same 
time, a multifunctional PEG-hydrogel with injectable, self-healing, 
antimicrobial, degradable, and superabsorbent properties was 
used as a novelty biomaterial to deliver the Agomir874 in IVDD. 
The mechanical performance of the PEG-hydrogel in single-seg-
ment intervertebral disk was  discussed for the first time. It was 
proved that the PEG-hydrogel has similar mechanical properties 
to normal intervertebral disk and can match and compensate 
for the elasticity of degenerated intervertebral disk. By injecting 
Agomir loaded in PEG-hydrogel, a gene-hydrogel microenviron-
ment was constructed in situ, which was proved to regulate the 
balance of metabolism of ECM in NPC of intervertebral disk in 
vivo, and  provide opportunities for intervertebral disk regenera-
tion so as to achieve the effect of treating IVDD. We also believe 
that this gene-hydrogel microenvironment can be applied in 
other diseases of which miRNAs contribute to the progress.
Adv. Sci. 2019, 1902099
Figure 5. Imaging data of animal experiments. a) Acupuncture model of rat coccygeal vertebrae. b) The X-ray images of rat coccygeal vertebrae. c) The 
intervertebral disc height (IDH) changes of different groups at different time points. d) The IDH changes of different groups at 1 week after surgery. 
e) The IDH changes of different groups at 4 weeks after surgery. f) The IDH changes of different groups at 8 weeks after surgery. g) The MRI images 
of rat coccygeal vertebrae. h) The gray scale changes of different groups at 8 weeks after surgery.
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